Report cover image

Myasthenia Gravis Treatment Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Oct 31, 2024
Length 128 Pages
SKU # PROD19315932

Description

Myasthenia Gravis Treatment Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global myasthenia gravis treatment market is expected to grow at a CAGR of around 7.0% during 2025-2034. This report on global myasthenia gravis treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global myasthenia gravis treatment market by segmenting the market based on drug class, age group, end use and region. Also, detailed profiles of companies operating in the myasthenia gravis treatment market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Growing Awareness
• Expanding Government Initiatives

Market Challenges

• Associated Side Effects

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Drug Class

• Intravenous Immunoglobulin
• Monoclonal Antibodies
• Cholinesterase Inhibitors
• Other Drugs

Market by Age Group

• Below 55 Years
• Above 55 Years

Market by End-Use

• Hospital Pharmacies
• Drug Store and Retail Pharmacies
• Online Providers

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

128 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Myasthenia Gravis Treatment Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Myasthenia Gravis Treatment Market Analysis
4.1. Market Portraiture
4.2. Market Drug Class
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Myasthenia Gravis Treatment Market by Drug Class
5.1. Introduction
5.2. Intravenous Immunoglobulin
5.3. Monoclonal Antibodies
5.4. Cholinesterase Inhibitors
5.5. Other Drugs
6. Global Myasthenia Gravis Treatment Market by Age Group
6.1. Introduction
6.2. Below 55 Years
6.3. Above 55 Years
7. Global Myasthenia Gravis Treatment Market by End-Use
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Drug Store and Retail Pharmacies
7.4. Online Providers
8. Global Myasthenia Gravis Treatment Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Astellas Pharma Inc.
12.2.2. AstraZeneca
12.2.3. Bausch Health Companies, Inc.
12.2.4. CSL Limited
12.2.5. F. Hoffmann-La Roche Ltd.
12.2.6. Grifols, S.A.
12.2.7. Kedrion, SpA
12.2.8. Novartis AG
12.2.9. Octapharma AG
12.2.10. Stryker Corporation
12.2.11. Veloxis Pharmaceuticals Inc.
12.2.12. Zydus Lifesciences Limited
List of Figures
Figure 1: Global Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 2: Global Myasthenia Gravis Treatment Market by Drug Class, 2024
Figure 3: Global Myasthenia Gravis Treatment Market by Age Group, 2024
Figure 4: Global Myasthenia Gravis Treatment Market by End-Use, 2024
Figure 5: Global Myasthenia Gravis Treatment Market by Region, 2024
Figure 6: Global Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 7: Global Myasthenia Gravis Treatment Market by Drug Class (in %), 2024 & 2034
Figure 8: Global Intravenous Immunoglobulin Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 9: Global Intravenous Immunoglobulin Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 10: Global Monoclonal Antibodies Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 11: Global Monoclonal Antibodies Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 12: Global Cholinesterase Inhibitors Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 13: Global Cholinesterase Inhibitors Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 14: Global Other Drugs Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 15: Global Other Drugs Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 16: Global Myasthenia Gravis Treatment Market by Age Group (in %), 2024 & 2034
Figure 17: Global Below 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 18: Global Below 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 19: Global Above 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 20: Global Above 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 21: Global Myasthenia Gravis Treatment Market by End-Use (in %), 2024 & 2034
Figure 22: Global Hospital Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 23: Global Hospital Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 24: Global Drug Store and Retail Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 25: Global Drug Store and Retail Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 26: Global Online Providers Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 27: Global Online Providers Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 28: Global Myasthenia Gravis Treatment Market by Region (in %), 2024 & 2034
Figure 29: Europe Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 30: Europe Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 31: Europe Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
Figure 32: Germany Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 33: United Kingdom Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 34: France Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 35: Italy Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 36: Spain Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 37: Russia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 38: Netherlands Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 39: North America Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 40: North America Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 41: North America Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
Figure 42: United States Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 43: Canada Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 44: Asia Pacific Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 45: Asia Pacific Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 46: Asia Pacific Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
Figure 47: China Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 48: Japan Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 49: India Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 50: South Korea Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 51: Australia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 52: Indonesia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 53: Latin America Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 54: Latin America Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 55: Latin America Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
Figure 56: Mexico Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 57: Brazil Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 58: Argentina Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 59: Middle East & Africa Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
Figure 60: Middle East & Africa Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
Figure 61: Middle East & Africa Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
Figure 62: Saudi Arabia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 63: Turkey Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 64: Iran Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 65: UAE Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
Figure 66: Market Value Chain
List of Tables
Table 1: Global Myasthenia Gravis Treatment Market Portraiture
Table 2: Global Myasthenia Gravis Treatment Market by Drug Class (in US$ Million), 2024 & 2034
Table 3: Global Myasthenia Gravis Treatment Market by Age Group (in US$ Million), 2024 & 2034
Table 4: Global Myasthenia Gravis Treatment Market by End-Use (in US$ Million), 2024 & 2034
Table 5: Global Myasthenia Gravis Treatment Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Myasthenia Gravis Treatment Market by Country (in US$ Million),
2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us